Utility of integrated HIV-1 DNA quantification in cure studies

被引：4
作者：
Ruggiero, Alessandra [1 ]
Malatinkova, Eva [2 ]
Rutsaert, Sofie [2 ]
Paxton, William A. [1 ]
Vandekerckhove, Linos [2 ]
De Spiegelaere, Ward [3 ]
机构：
[1] Univ Liverpool, Inst Infect & Global Hlth, Dept Clin Infect Microbiol & Immunol CIMI, Liverpool, Merseyside, England
[2] Univ Ghent, Fac Med & Hlth Sci, Dept Internal Med, HIV Cure Res Ctr, Ghent, Belgium
[3] Univ Ghent, Fac Vet Sci, Dept Morphol, Ghent, Belgium
来源：
FUTURE VIROLOGY | 2017年 / 12卷 / 04期
基金：
比利时弗兰德研究基金会;
关键词：
Alu-gag PCR; HIV-1; reservoir; integrated HIV-1 DNA; replication competency; HISTONE DEACETYLASE INHIBITORS; CD4(+) T-CELLS; SUPPRESSIVE ANTIRETROVIRAL THERAPY; LATENT RESERVOIR; PERIPHERAL-BLOOD; RALTEGRAVIR INTENSIFICATION; ONGOING REPLICATION; DISEASE PROGRESSION; TYPE-1; REPLICATION; VIRAL PERSISTENCE;
D O I：
10.2217/fvl-2016-0130
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Numerous HIV-1 curative strategies have been proposed to eradicate the virus reservoir pool that remains integrated within target cells, despite successful antiretroviral therapy. To test the impact of such interventions on this reservoir, a universal marker of persistence is needed. Quantifying integrated HIV-1 DNA load has been proposed as a strong virological marker. In this paper, we provide a detailed description of the most commonly used assays to quantify integrated HIV-1 DNA and applications in relevant clinical studies produced over the last 20 years with a major focus on the recent literature. We discuss the potential for using this marker of virological persistence and the technical limitations that need to be addressed.
引用
收藏
页码：215 / 225
页数：11
相关论文
共 88 条
  • [41] Antiretroviral Therapy Initiated Within 6 Months of HIV Infection Is Associated With Lower T-Cell Activation and Smaller HIV Reservoir Size
    Jain, Vivek
    Hartogensis, Wendy
    Bacchetti, Peter
    Hunt, Peter W.
    Hatano, Hiroyu
    Sinclair, Elizabeth
    Epling, Lorrie
    Lee, Tzong-Hae
    Busch, Michael P.
    McCune, Joseph M.
    Pilcher, Christopher D.
    Hecht, Frederick M.
    Deeks, Steven G.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2013, 208 (08) : 1202 - 1211
  • [42] Integrated and Total HIV-1 DNA Predict Ex Vivo Viral Outgrowth
    Kiselinova, Maja
    De Spiegelaere, Ward
    Buzon, Maria Jose
    Malatinkova, Eva
    Lichterfeld, Mathias
    Vandekerckhove, Linos
    [J]. PLOS PATHOGENS, 2016, 12 (03)
  • [43] Dynamics of total, linear nonintegrated, and integrated HIV-1 DNA in vivo and in vitro
    Koelsch, Kersten K.
    Liu, Lin
    Haubrich, Richard
    May, Susanne
    Havlir, Diane
    Guenthard, Huldrych F.
    Ignacio, Caroline C.
    Campos-Soto, Paula
    Little, Susan J.
    Shafer, Robert
    Robbins, Gregory K.
    D'Aquila, Richard T.
    Kawano, Yuji
    Young, Karen
    Dao, Phillip
    Spina, Celsa A.
    Richman, Douglas D.
    Wong, Joseph K.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2008, 197 (03) : 411 - 419
  • [44] Impact of treatment with raltegravir during primary or chronic HIV infection on RNA decay characteristics and the HIV viral reservoir
    Koelsch, Kersten K.
    Boesecke, Christoph
    McBride, Kristin
    Gelgor, Linda
    Fahey, Paul
    Natarajan, Ven
    Baker, David
    Bloch, Mark
    Murray, John M.
    Zaunders, John
    Emery, Sean
    Cooper, David A.
    Kelleher, Anthony D.
    [J]. AIDS, 2011, 25 (17) : 2069 - 2078
  • [45] Rapid Quantification of the Latent Reservoir for HIV-1 Using a Viral Outgrowth Assay
    Laird, Gregory M.
    Eisele, Evelyn E.
    Rabi, S. Alireza
    Lai, Jun
    Chioma, Stanley
    Blankson, Joel N.
    Siliciano, Janet D.
    Siliciano, Robert F.
    [J]. PLOS PATHOGENS, 2013, 9 (05)
  • [46] Combined eff ect of Vacc-4x, recombinant human granulocyte macrophage colony-stimulating factor vaccination, and romidepsin on the HIV-1 reservoir (REDUC): a single-arm, phase 1B/2A trial
    Leth, Steffen
    Schleimann, Mariane H.
    Nissen, Sara K.
    Hojen, Jesper F.
    Olesen, Rikke
    Graversen, Mette E.
    Jorgensen, Sofi E.
    kjaer, Anne Sofie
    Denton, Paul W.
    Mork, Alejandra
    Sommerfelt, Maja A.
    Krogsgaard, Kim
    Ostergaard, Lars
    Rasmussen, Thomas A.
    Tolstrup, Martin
    Sogaard, Ole Schmeltz
    [J]. LANCET HIV, 2016, 3 (10): : E463 - E472
  • [47] Detecting HIV-1 integration by repetitive-sampling (Alu)under-bar-gag PCR
    Liszewski, Megan K.
    Yu, Jianqing J.
    O'Doherty, Una
    [J]. METHODS, 2009, 47 (04) : 254 - 260
  • [48] Persistent HIV-1 replication maintains the tissue reservoir during therapy
    Lorenzo-Redondo, Ramon
    Fryer, Helen R.
    Bedford, Trevor
    Kim, Eun-Young
    Archer, John
    Pond, Sergei L. Kosakovsky
    Chung, Yoon-Seok
    Penugonda, Sudhir
    Chipman, Jeffrey G.
    Fletcher, Courtney V.
    Schacker, Timothy W.
    Malim, Michael H.
    Rambaut, Andrew
    Haase, Ashley T.
    McLean, Angela R. .
    Wolinsky, Steven M.
    [J]. NATURE, 2016, 530 (7588) : 51 - +
  • [49] Impact of a decade of successful antiretroviral therapy initiated at HIV-1 seroconversion on blood and rectal reservoirs
    Malatinkova, Eva
    De Spiegelaere, Ward
    Bonczkowski, Pawel
    Kiselinova, Maja
    Vervisch, Karen
    Trypsteen, Wim
    Johnson, Margaret
    Verhofstede, Chris
    de Looze, Danny
    Murray, Charles
    Kiloch-de Loes, Sabine
    Vandekerckhove, Linos
    [J]. ELIFE, 2015, 4
  • [50] Specific HIV integration sites are linked to clonal expansion and persistence of infected cells
    Maldarelli, F.
    Wu, X.
    Su, L.
    Simonetti, F. R.
    Shao, W.
    Hill, S.
    Spindler, J.
    Ferris, A. L.
    Mellors, J. W.
    Kearney, M. F.
    Coffin, J. M.
    Hughes, S. H.
    [J]. SCIENCE, 2014, 345 (6193) : 179 - 183
123456789